SPOTLIGHT -
Slideshow
Author(s):
Outpatient treatment sees modest growth, outcome expectancy varies with treatment type and time, “next steps” proposed for depression remission-here’s a brief look at some of the latest findings.
The Double-Edged Sword of Affluence
Blue Light Blockers: A Behavior Therapy for Mania
FDA Filing Fee Waiver for New Drug Application of NRX-100 for Suicidal Depression
Treating ‘Morally Objectionable’ Patients
Preliminary Results from RESTORE-LIFE Shows Promise for VNS in Difficult to Treat Depression
MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder